For female BRCA1/2 carriers, risk-reducing salpingo-oophorectomy (RRSO) decreases the risk of ovarian and breast cancer (BC) by >80% and 50%, respectively, with a 77% reduction in all-cause mortality [20–22]. This evidence concerns the gene BRCA1 and breast carcinoma.